Achieve Life Sciences (ACHV) EBIT (2010 - 2018)
Achieve Life Sciences (ACHV) posted EBIT of $43.5 million for Q4 2018, up 2486.72% on a QoQ basis from -$1.8 million in Q3 2018, and up 1344.59% year-over-year from $3.0 million in Q4 2017.
Achieve Life Sciences (ACHV) EBIT (2010 - 2018) Analysis & Trends
Achieve Life Sciences' EBIT history runs 7 years deep, the most recent figure standing at $43.5 million for Q4 2018.
- Quarterly EBIT rose 1344.59% year-over-year to $43.5 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $38.7 million (up 12.96% YoY) and the FY2019 annual result came in at -$16.2 million, down 147.1% from the prior year.
- EBIT was $43.5 million for Q4 2018 at Achieve Life Sciences, up from -$1.8 million in the prior quarter.
- Across five years, EBIT topped out at $45.7 million in Q1 2017 and bottomed at -$7.8 million in Q3 2017.
- A 4-year average of $6.6 million and a median of -$567000.0 in 2016 frame the typical range for EBIT.
- Annual changes were most pronounced in 2017 — EBIT slumped 2444.26% — and 2018, when it surged 1344.59%.
- Achieve Life Sciences' EBIT stood at $392000.0 in 2015, then plunged by 244.64% to -$567000.0 in 2016, then plunged by 516.23% to -$3.5 million in 2017, then jumped by 1344.59% to $43.5 million in 2018.
- Business Quant data shows ACHV's EBIT at $43.5 million in Q4 2018, -$1.8 million in Q3 2018, and -$1.4 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 43.49 Mn |
| Sep 30, 2018 | -1.82 Mn |
| Jun 30, 2018 | -1.37 Mn |
| Mar 31, 2018 | -1.60 Mn |
| Dec 31, 2017 | -3.49 Mn |
| Sep 30, 2017 | -7.76 Mn |
| Jun 30, 2017 | -166,000.00 |
| Mar 31, 2017 | 45.67 Mn |
| Dec 31, 2016 | -567,000.00 |
| Sep 30, 2016 | -305,000.00 |
| Dec 31, 2015 | 392,000.00 |
| Dec 31, 2012 | 35.52 Mn |
| Sep 30, 2012 | 8.29 Mn |
| Jun 30, 2012 | 5.94 Mn |
| Mar 31, 2012 | -5.50 Mn |
| Dec 31, 2011 | -86.68 Mn |
| Sep 30, 2011 | 4.10 Mn |
| Jun 30, 2011 | 4.99 Mn |
| Mar 31, 2011 | -5.23 Mn |
| Dec 31, 2010 | -2.80 Mn |